GREY:IPHAF - Post by User
Comment by
antoninuson Apr 28, 2010 10:39am
440 Views
Post# 17039240
and by the way...
and by the way...on balance, I think isa management has been ok. If I were grading it, I would give it a c+ to a b-
they did develop a nice drug, they did get roche on board, they did attract paladin, who are an excellent partner of sorts, they did make the deal with lux which is proving to be a liferaft.
Question for you. If you were the ceo of isa and had it all to do over again, would you do it exactly the same? gmscle, are you satisfied that near 10 yrs later, with a multi indication / multi platform drug in P2B, P3 as well as an indication in fast tracking mode , are you satisfied that we are a .35 cent stock with 130 million shares out and next to no money left? Do you think any of this was avoidable or are we here entirely due to market forces?